Stock Report

All about this stock under one free report Last Updated: 23-Sep-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Mukka Proteins Peer Comparison

Stock Card factsheet watchlist-stock-modal share-fund-plan-icon

NSE: MUKKA | BSE: 544135

₹27.10

up-down-arrow ₹-0.27 (-0.99%)

As on 23-Sep-2026IST

Market cap

info icon

₹806 Cr

Revenue (TTM)

info icon

₹1,768 Cr

P/E Ratio

info icon

11.7

P/B Ratio

info icon

1.6

Div. Yield

info icon

0 %

Edit peer-selector-edit
Mukka Proteins Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Market cap (₹ Cr)
 806 34,201 15,745 14,413 9,226
Revenue (₹ Cr)
 1,768 2,250 3,172 3,813 950
Net Profit (₹ Cr)
 72.56 361.74 521.27 400.90 266.00
Net Margin (%)
 4.04 15.77 15.92 10.30 27.44
RoE (%)
 14.65 15.47 18.10 13.87 72.69
Price to Earnings
 11.67 94.55 30.47 35.95 34.68
Price-To-Book
 1.55 13.40 4.95 4.49 26.52

Income Statement (₹ Cr)

Mukka Proteins Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Operating Revenue arrow
1,449.45 2,192.49 2,950.94 3,510.50 878.40
Total Income arrow
1,478.13 2,266.90 3,033.47 3,582.50 896.80
Total Expenditure arrow
1,334.87 1,584.97 2,350.16 2,891.50 569.40
EBITDA arrow
114.58 607.53 600.78 619.00 309.00
Depreciation arrow
16.59 166.86 98.63 126.40 11.70
EBIT arrow
97.99 440.67 502.15 492.60 297.30
Interest arrow
53.60 40.88 24.13 19.30 2.00
Other Income arrow
28.68 74.40 82.53 72.00 18.40
Exceptional Items arrow
-- -8.00 -- -20.30 6.60
Profit before Tax arrow
75.14 466.19 560.56 525.00 320.30
Provision for Tax arrow
18.06 117.28 140.49 123.90 80.20
Profit after Tax arrow
57.09 348.91 420.06 401.10 240.10

Liabilities (₹ Cr)

Mukka Proteins Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Shareholder's Funds arrow
499.09 2,483.69 3,023.16 3,138.70 384.00
Minority Interest arrow
29.69 -- 29.52 -- --
Non-Current Liabilities arrow
43.05 321.65 268.17 318.60 229.90
Current Liabilities arrow
1,048.93 904.59 527.09 1,086.20 128.40
Total Liabilities arrow
1,621.13 3,709.93 3,855.82 4,620.30 750.80

Assets (₹ Cr)

Mukka Proteins Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Non-Current Assets arrow
331.92 2,228.49 1,125.20 1,925.10 248.00
Current Assets arrow
1,288.83 1,481.44 2,722.74 2,618.40 494.30
Total Assets arrow
1,621.13 3,709.93 3,855.82 4,620.30 750.80
Total Debt* arrow
767.77 95.13 29.59 0.00 0.00
Net Current Assets arrow
239.90 576.85 2,195.65 1,532.20 365.90
Contingent Liabilities arrow
61.31 97.31 -- -- 1.50

Cashflow (₹ Cr)

Mukka Proteins Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Cash From Operating Activities arrow
-111.27 509.13 458.13 650.80 174.80
Cash Flow from Investing Activities arrow
-145.98 -395.41 -248.27 -512.40 7.60
Cash from Financing Activities arrow
267.05 -123.68 -70.93 -82.60 -134.50
Net Cash Inflow / Outflow arrow
9.81 -9.96 138.93 55.80 47.90

Ratios

Profitability Ratios

 Mukka Proteins Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
ROCE (%) arrow
11.93 20.97 21.10 18.92 98.11
ROE (%) arrow
12.15 15.16 15.31 14.14 73.20
ROA (%) arrow
4.23 10.09 11.85 10.31 37.26
EBIT Margin (%) arrow
9.88 31.10 23.16 19.68 37.27
Net Margin (%) arrow
3.86 15.39 13.85 11.20 26.77
Cash Profit Margin (%) arrow
4.98 23.50 17.07 15.03 27.35

Growth Ratios

 Mukka Proteins Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Revenue Growth (%) arrow
44.02 29.38 12.51 23.64 21.24
EBIT Growth (%) arrow
30.24 53.37 14.07 7.72 15.44
Net Profit Growth (%) arrow
18.69 105.08 9.79 -1.38 32.65
EPS Growth (%) arrow
12.06 101.82 9.81 -1.79 32.65
Book Value Growth (%) arrow
13.25 16.76 22.41 19.89 41.18

Valuation Ratios

 Mukka Proteins Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Price / Earnings arrow
10.60 58.91 17.04 26.06 43.36
Price / Book Value arrow
1.11 8.29 2.36 3.38 27.11
Dividend Yield (%) arrow
0.00 0.00 0.57 0.52 1.66
EV/EBITDA arrow
8.79 30.12 9.02 14.57 30.65
Market Cap (₹ Cr) arrow
551.66 20,554.39 7,121.50 10,450.76 10,410.62

Solvency Ratios

 Mukka Proteins Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Debt to Equity arrow
1.54 0.04 0.01 0.00 0.00
Short term debt to equity ratio arrow
1.44 0.03 0.01 -- --
Current Ratio arrow
1.23 1.64 5.17 2.41 3.85
Quick Ratio arrow
0.41 1.47 3.32 2.41 3.37
Interest Coverage arrow
2.40 12.40 24.24 28.20 161.15

Operating Efficiency Ratios

 Mukka Proteins Sai Life Sciences Marksans Pharma Indegene Sanofi Consumer Healthcare India
Debtors to sales (%) arrow
12.55 17.04 21.84 27.97 3.37
Asset Turnover arrow
1.10 0.63 0.86 0.90 1.43
Receivable days arrow
47.06 60.56 71.16 90.10 8.58
Inventory Days arrow
175.18 22.43 109.20 0.00 20.38
Payable days arrow
59.68 194.31 91.82 -- 118.89
Cash Conversion Cycle arrow
162.56 -111.32 88.55 -- -89.93
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...
loading...
loading...
loading...